HÜRMÜZ, P. Et Al. 2020. Treatment outcomes of metastasis-directed treatment using(68)Ga-PSMA-PET/CT for oligometastatic or oligorecurrent prostate cancer: Turkish Society for Radiation Oncology group study (TROD 09-002). STRAHLENTHERAPIE UND ONKOLOGIE , vol.196, no.11 , 1034-1043.

HÜRMÜZ, P., Onal, C., ÖZYİĞİT, G., Igdem, S., ATALAR, B., Sayan, H., ... Akgun, Z.(2020). Treatment outcomes of metastasis-directed treatment using(68)Ga-PSMA-PET/CT for oligometastatic or oligorecurrent prostate cancer: Turkish Society for Radiation Oncology group study (TROD 09-002). STRAHLENTHERAPIE UND ONKOLOGIE , vol.196, no.11, 1034-1043.

HÜRMÜZ, PERVİN Et Al. "Treatment outcomes of metastasis-directed treatment using(68)Ga-PSMA-PET/CT for oligometastatic or oligorecurrent prostate cancer: Turkish Society for Radiation Oncology group study (TROD 09-002)," STRAHLENTHERAPIE UND ONKOLOGIE , vol.196, no.11, 1034-1043, 2020

HÜRMÜZ, PERVİN Et Al. "Treatment outcomes of metastasis-directed treatment using(68)Ga-PSMA-PET/CT for oligometastatic or oligorecurrent prostate cancer: Turkish Society for Radiation Oncology group study (TROD 09-002)." STRAHLENTHERAPIE UND ONKOLOGIE , vol.196, no.11, pp.1034-1043, 2020

HÜRMÜZ, P. Et Al. (2020) . "Treatment outcomes of metastasis-directed treatment using(68)Ga-PSMA-PET/CT for oligometastatic or oligorecurrent prostate cancer: Turkish Society for Radiation Oncology group study (TROD 09-002)." STRAHLENTHERAPIE UND ONKOLOGIE , vol.196, no.11, pp.1034-1043.

@article{article, author={PERVİN HÜRMÜZ Et Al. }, title={Treatment outcomes of metastasis-directed treatment using(68)Ga-PSMA-PET/CT for oligometastatic or oligorecurrent prostate cancer: Turkish Society for Radiation Oncology group study (TROD 09-002)}, journal={STRAHLENTHERAPIE UND ONKOLOGIE}, year=2020, pages={1034-1043} }